I agree that this site is using cookies. You can find further informations here.
X
Fenaux, Pierre
811  results:
Search for persons X
?
1

Sabatolimab plus hypomethylating agents in previously untre..:

Zeidan, Amer M ; Ando, Kiyoshi ; Rauzy, Odile...
The Lancet Haematology.  11 (2024)  1 - p. e38-e50 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Clinical impact of genetic alterations including germline D..:

Sébert, Marie ; Freiman, Lucie ; Chaffaut, Cendrine...
Leukemia.  38 (2024)  4 - p. 918-922 , 2024
Link: https://doi.org/10.1038/..
 
?
3

Niclosamide combined to Azacitidine to target TP53-mutated ..:

Maslah, Nabih ; Rety, Salome ; Bonnamy, Melina...
Leukemia.  , 2024
Link: https://doi.org/10.1038/..
 
?
4

Molecular alterations monitoring in myelodysplastic patient..:

Robin, Marie ; Nibourel, Olivier ; Tournaire, Martin...
Bone Marrow Transplantation.  , 2024
Link: https://doi.org/10.1038/..
 
?
5

Imetelstat in patients with lower-risk myelodysplastic synd..:

Platzbecker, Uwe ; Santini, Valeria ; Fenaux, Pierre...
The Lancet.  403 (2024)  10423 - p. 249-260 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Kidney involvement in myelodysplastic syndromes:

Lafargue, Marie-Camille ; Van Huyen, Jean-Paul Duong ; Rennke, Helmut G...
Clinical Kidney Journal.  , 2024
Link: https://doi.org/10.1093/..
 
?
7

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Ph..:

Konopleva, Marina Y. ; Dail, Monique ; Daver, Naval G....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  6 - p. 364-374 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Toward a more patient‐centered drug development process in ..:

Efficace, Fabio ; Buckstein, Rena ; Abel, Gregory A....
HemaSphere.  8 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
9

Accelerated DNA replication fork speed due to loss of R-loo..:

Rombaut, David ; Lefèvre, Carine ; Rached, Tony...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
10

Cutaneous clonal mature plasmacytoid dendritic cell dermato..:

Mahévas, Thibault ; Osio, Amélie ; Larcher, Lise...
Blood Advances.  8 (2024)  12 - p. 3293-3298 , 2024
Link: https://doi.org/10.1182/..
 
?
11

Olutasidenib in post-venetoclax patients with mutant isocit..:

Cortes, Jorge ; Jonas, Brian A. ; Schiller, Gary...
Leukemia & Lymphoma.  , 2024
Link: https://doi.org/10.1080/..
 
?
12

Germline CHEK2 mutations in patients with myeloid neoplasms:

Freiman, Lucie ; Larcher, Lise ; Tueur, Giulia...
Leukemia.  38 (2024)  4 - p. 908-911 , 2024
Link: https://doi.org/10.1038/..
 
?
13

Guadecitabine vs TC in relapsed/refractory AML after intens..:

Roboz, Gail J. ; Sanz, Guillermo ; Griffiths, Elizabeth A....
Blood Advances.  8 (2024)  8 - p. 2020-2029 , 2024
Link: https://doi.org/10.1182/..
 
?
14

#2663 KIDNEY INVOLVEMENT IN MYELODYSPLASTIC SYNDROMES:

Lafargue, Marie-Camille ; Van Huyen, Jean-Paul Duong ; Isnard, Pierre...
Nephrology Dialysis Transplantation.  38 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
15

Allogeneic transplantation in acute myelogenous leukemia: a..:

Socie, Gerard ; Galimard, Jacques-Emmanuel ; Raffoux, Emmanuel...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
1-15